68
Views
4
CrossRef citations to date
0
Altmetric
Perspectives

Keratoprosthesis prophylaxis: is it time for a paradigm shift?

, &
Pages 1785-1788 | Published online: 12 Sep 2018

References

  • OlivaMSSchottmanTGulatiMTurning the tide of corneal blindnessIndian J Ophthalmol201260542342722944753
  • Harissi-DagherMKhanBFSchaumbergDADohlmanCHImportance of nutrition to corneal grafts when used as a carrier of the Boston KeratoprosthesisCornea200726556456817525653
  • DohlmanCHHarissi-DagherMKhanBFIntroduction to the use of the Boston keratoprosthesisExpert Rev Ophthalmol2006114148
  • Salvador-CullaBKolovouPEKeratoprosthesis: A Review of Recent Advances in the FieldJ Funct Biomater20167213
  • WagonerMDWelderJDGoinsKMGreinerMAMicrobial Keratitis and Endophthalmitis After the Boston Type 1 KeratoprosthesisCornea201635448649326764885
  • RobertMCEidEPSaint-AntoinePHarissi-DagherMMicrobial colonization and antibacterial resistance patterns after Boston type 1 keratoprosthesisOphthalmology201312081521152823601798
  • NouriMTeradaHAlfonsoECEndophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factorsArch Ophthalmol2001119448448911296013
  • BehlauIMartinKVMartinJNInfectious endophthalmitis in Boston keratoprosthesis: incidence and preventionActa Ophthalmol2014927e546e55524460594
  • Zarei-GhanavatiSBetancurtCMasAMWangJPerezVLUltra high resolution optical coherence tomography in Boston type I keratoprosthesisJ Ophthalmic Vis Res2015101263226005549
  • ChanCCHollandEJInfectious keratitis after Boston type 1 keratoprosthesis implantationCornea201231101128113422960647
  • SejpalKYuFAldaveAJThe Boston keratoprosthesis in the management of corneal limbal stem cell deficiencyCornea201130111187119421885964
  • BarnesSDDohlmanCHDurandMLFungal colonization and infection in Boston keratoprosthesisCornea200726191517198007
  • Harvard Medical SchoolRecommendations Boston KPro Follow-upBoston, MAHarvard Medical School Available from: https://eye.hms.harvard.edu/eyeinsights/2015-september/recommendations-for-boston-kpro-follow-upAccessed September 10, 2018
  • KimSJTomaHSOphthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injectionsOphthalmology201111871358136321420176
  • MilderEvanderJShahCGargSChanges in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injectionOphthalmology201211971420142422420958
  • BarnesSDDohlmanCHDurandMLFungal colonization and infection in Boston keratoprosthesisCornea200726191517198007
  • ChanCCHollandEJInfectious endophthalmitis after Boston type 1 keratoprosthesis implantationCornea201231434634922314825
  • GreinerMALiJYMannisMJLonger-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, DavisOphthalmology201111881543155021397948
  • OdorcicSHaasWGilmoreMSDohlmanCHFungal Infections After Boston Type 1 Keratoprosthesis Implantation: Literature Review and In Vitro Antifungal Activity of Hypochlorous AcidCornea201534121599160526488624
  • MagalhãesFPdo NascimentoHMEckerDJMicrobiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodineCornea201332440741122488148
  • Lanker KlossnerBWidmerHRFreyFNondevelopment of resistance by bacteria during hospital use of povidone-iodineDermatology1997195Suppl 21013
  • HsuJGerstenblithATGargSJvanderJFConjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibioticsAm J Ophthalmol2014157351451824332373
  • GrzybowskiAKanclerzPMyersWGThe use of povidone-iodine in ophthalmologyCurr Opin Ophthalmol2018291193228984794
  • GoldenheimPDIn vitro efficacy of povidone-iodine solution and cream against methicillin-resistant Staphylococcus aureusPostgrad Med J199369Suppl 3S62S658290460
  • TraoréOFayardSFLaveranHAn in-vitro evaluation of the activity of povidone-iodine against nosocomial bacterial strainsJ Hosp Infect19963432172228923277
  • WadaHNojimaYOgawaSRelationship between Virucidal Efficacy and Free Iodine Concentration of Povidone-Iodine in Buffer SolutionBiocontrol Sci2016211212727009506
  • PanahibazazMMoosavianMKhataminiaGSub-Conjunctival Injection of Antibiotics vs. Povidone-Iodine Drop on Bacterial Colonies in Phacoemulsification Cataract SurgeryJundishapur J Microbiol201479e1310825485065
  • González BandrésCCarrilero FerrerMJBuznego SuárezLEfficacy of topical povidone-iodine applied the day before cataract surgery to reduce conjunctival floraArch Soc Esp Oftalmol200176422923411340513
  • HoekstraMJWestgateSJMuellerSPovidone-iodine ointment demonstrates in vitro efficacy against biofilm formationInt Wound J201714117217926968574
  • SivaramanKRHouJHChangJHScanning Electron Microscopic Analysis of Biofilm Formation in Explanted Human Boston Type I KeratoprosthesesCornea2016351252926562818
  • PelletierJSCapriottiKDStewartKSBaroneSBCapriottiJAA novel transdermal ophthalmic preparation for blepharitis in a dilute povidone-iodine and dimethyl sulfoxide (DMSO) system: a case seriesEC Ophthalmology201893129134
  • PelletierJSStewartKPCapriottiKCapriottiJARosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the LiteratureOphthalmol Ther20154214315026525679
  • PelletierJSCapriottiKStewartKSCapriottiJADemodex blepharitis treated with a novel dilute povidone-iodine and DMSO System: a case reportOphthalmol Ther20176236136628643231
  • PelletierJSStewartKTrattlerWA combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitisAdv Ther200926877678319756415